Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

566
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
566
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

617
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
617
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

597
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
597
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

739
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
739
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

516
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy.

Circulation. Heart failure·2026
Same author

Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

Nature medicine·2026
Same author

Media representations of rural and coastal cancer inequalities in the UK: A 10-year retrospective place-based analysis.

Health & place·2026
Same author

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same author

Evaluating the temporal and sociodemographic generalizability of the emergency heart failure mortality risk grade.

ESC heart failure·2026
Same author

Preparation for online psychological therapy for depression in people living with and beyond cancer in East Midlands NHS primary and secondary care services in England: protocol for the PROSPER randomised controlled trial.

BMJ open·2026

Related Experiment Video

Updated: Apr 10, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.2K

Heart Failure Guideline-Directed Medical Therapy Scoring Systems: A Scoping Review.

Aaryan Dwivedi1, Zachary Cox2, Nathaniel M Hawkins1

  • 1Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada (A.D., N.M.H., N.M., S.V.).

Circulation. Heart Failure
|April 9, 2026
PubMed
Summary
This summary is machine-generated.

No standard metric exists for heart failure with reduced ejection fraction guideline-directed medical therapy (GDMT). A review found many disparate scores, highlighting gaps in quantifying optimal, tolerated therapy and incorporating new drugs.

Keywords:
drug therapyheart failure

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.5K

Related Experiment Videos

Last Updated: Apr 10, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.2K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.5K

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Research

Background:

  • Guideline-directed medical therapy (GDMT) is crucial for heart failure with reduced ejection fraction (HFrEF).
  • A lack of standardized metrics hinders the quantification of GDMT implementation in clinical practice.
  • This study addresses the need for a consistent measure of GDMT adherence.

Purpose of the Study:

  • To conduct a scoping review of published heart failure GDMT scores.
  • To characterize these scores and summarize their use in clinical studies.
  • To identify gaps and inconsistencies in current GDMT quantification methods.

Main Methods:

  • A comprehensive scoping review was performed.
  • Searches included MEDLINE, Embase, CENTRAL, and Web of Science (October 2020 - March 2025).
  • 26 studies (354,281 patients) were included from 544 records, analyzing 25 different GDMT scores.

Main Results:

  • 25 distinct GDMT scores were identified, with 13 adaptations of the Optimal Medical Therapy score.
  • Most scores included renin-angiotensin system inhibitors (RASi), beta-blockers, and mineralocorticoid receptor antagonists.
  • Few scores accounted for sacubitril-valsartan, SGLT2 inhibitors, contraindications, or intolerance.

Conclusions:

  • Multiple, varied scores for HFrEF GDMT optimization exist, diluting their effectiveness.
  • Key limitations include inconsistent drug class weighting, poor incorporation of intolerance, and limited inclusion of newer therapies.
  • Future research should prioritize clear reporting, justification of chosen scores, and utilization of contemporary, comprehensive metrics.